Form 483

Granules India Limited Form 483, 2020-02-14

FDA issued a Form 483 to Granules India Limited on 2020-02-14 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Granules India Limited · Medchal-Malkhajgiri District, India · Issued February 14, 2020

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Feb 2020
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Darren S Brown, Jose A Lopez Rubet

14 Feb 2020
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Darren S Brown, Jose A Lopez Rubet

Inspected site

GIGranules India LimitedMedchal-Malkhajgiri District, India

Inspection team

JAJose A Lopez Rubet

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere